TickerKhojComparison · NSE · data 2026-11-02
Anlon Healthcare Limited vs NGL Fine-Chem Ltd.
In plain words
Size: NGL Fine-Chem Ltd. is about 1.1 times the market value of Anlon Healthcare Limited.
Valuation (P/E): Anlon Healthcare Limited 37.7 vs NGL Fine-Chem Ltd. 27.8.
Return on equity: Anlon Healthcare Limited 18.4% vs NGL Fine-Chem Ltd. 15.7%.
Profit growth over 3 years: Anlon Healthcare Limited 69.8% a year vs NGL Fine-Chem Ltd. 32.9% a year.
Debt to equity: NGL Fine-Chem Ltd. 0.37 vs Anlon Healthcare Limited 0.19.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AHCL | NGLFINE | |
|---|---|---|
| Price | ₹25.33 | ₹2,574 |
| Market cap | ₹1,378 cr | ₹1,576 cr |
| P/E | 37.7 | 27.8 |
| P/B | 5.2 | — |
| ROE | 18.4% | 15.7% |
| ROCE | 24.3% | 17.1% |
| Debt / equity | 0.19 | 0.37 |
| Operating margin | 23.5% | 11.9% |
| Dividend yield | 0.00% | 0.07% |
| Sales growth, 3 years (yearly) | 15.1% | 21.7% |
| Profit growth, 3 years (yearly) | 69.8% | 32.9% |
| 1-year return | 95.0% | 68.8% |
| Revenue, last 12 months | ₹280 cr | ₹536 cr |
| Net profit, last 12 months | ₹36 cr | ₹57 cr |
| Latest quarter | Sept 2026 | Jun 2026 |
| Quarter net profit | ₹13 cr | ₹18 cr |
| Quarter profit vs a year earlier | +43.5% | +99.1% |
| Promoter holding | 52.68% | 72.49% |
| Health check | Strong (8/10) | Strong (8.3/10) |
Common questions
Which has a higher P/E, Anlon Healthcare Limited or NGL Fine-Chem Ltd.?
Anlon Healthcare Limited trades at the higher P/E (37.7 against 27.8). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Anlon Healthcare Limited (18.4% against 15.7%).
Which carries more debt?
NGL Fine-Chem Ltd. has the higher debt-to-equity ratio (0.37 against 0.19).